FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-001067-51-ES
Enrollment
Unknown
Registered
2012-04-17
Start date
2011-11-28
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: HLT Classification code 10035660 Term: Pneumocystis infections System Organ Class: 10021881 - Infections and infestations

Interventions

Trade Name: Beta-lactamicos Product Name: Beta-lactamicos Product Code: Beta-lactamicos Pharmaceutical Form: Solution for injection/infusion INN or Proposed INN: no CAS Number: no Current Sponsor code

Sponsors

Alberto Capelastegui Sainz
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 1090 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Secondary

MeasureTime frame
Timepoint(s) of evaluation of this end point: No—

Countries

Spain

Contacts

Public ContactAlberto Capelastegui Sainz

Alberto Capelastegui Sainz

alberto.capelasteguisainz@osakidetza.net+34944007000

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026